My biggest REIT wound. 229 shares at an average of €5.45 — currently at €4.41. Book loss €237. Plus €119 in received dividends brings the net position to minus €118. That is the situation as of April 30, 2026 — the day MPT (Medical Properties Trust, NYSE: MPW) publishes its Q1 2026 earnings. Transparency is mandatory, so here is the full analysis with no sugarcoating.
But is MPW a comeback candidate or a classic yield trap? I am looking at this systematically: the three crash bombs, the Q4 2025 turnaround, and what Q1 2026 must show.
1. What Is Medical Properties Trust?
MPW is not a conventional REIT. It is a hospital landlord — the company buys hospitals and leases them back long-term (typically 15–20 years) to hospital operators. With over 400 hospitals in nine countries (USA, UK, Germany, Australia, Switzerland, Finland, Colombia, Portugal, Spain), MPW is one of the largest hospital property owners in the world.
The business model sounds defensive: healthcare is not a cyclical industry, leases are long, and demand for hospitals is structurally stable. That is true — as long as the tenants are stable. And that is precisely where the problem lay.
2. The Three Crash Bombs (2023–2025)
Bomb 1: Steward Health Care Bankruptcy (2024)
Steward was MPW’s largest single tenant — roughly 20% of the entire rental income portfolio. In 2024, Steward filed for bankruptcy under Chapter 11. MPW was forced to take massive write-downs and initially received no regular rent payments. The restructuring took months and consumed significant management capacity. Many of the Steward hospitals were ultimately transferred to new operators or closed.
Bomb 2: Prospect Medical Distress (2024–2025)
Prospect Medical, another major tenant, also ran into financial difficulties and could not fully meet its rent obligations. California hospitals were particularly affected. MPW had to take valuation adjustments and negotiate solutions while investors priced in worst-case scenarios.
Bomb 3: The Dividend Staircase Down
The combined rent defaults forced MPW into three dividend cuts: from $0.29/quarter → $0.15 → $0.09 = minus 70%. Every cut triggered another wave of selling. Anyone who bought at $0.29 and relied on a stable dividend was disappointed three times over.
3. Q4 2025 Turnaround — First Profitable Quarter
Q4 2025 brought the first positive data point in a long time: MPW posted a net profit of +$17 million — the first profitable quarter after a prolonged period of losses. This is not a breakthrough, but it is a clear signal that the worst write-down effects are behind it.
Simultaneously: the dividend was confirmed stable at $0.09. This matters. If MPW can start growing again and the dividend stays stable, the current yield of 7.4% at the end of the cycle is an interesting base.
4. The Business Model — Not a Standard REIT
To properly assess MPW, one needs to understand the business model. MPW is a sale-leaseback specialist for hospital real estate. A hospital operator sells its buildings to MPW and immediately leases them back — it gets fresh capital for growth or debt reduction; MPW gets a long-term tenant and predictable rent cash flows.
The structural advantage: hospitals cannot simply relocate like office tenants. The medical infrastructure (operating rooms, ICUs, emergency departments, licenses) is location-bound. That makes MPW as a landlord theoretically very strong — provided the tenants themselves are financially stable.
The Steward disaster demonstrated this: if a hospital operator runs with too much debt and operational efficiency declines, it can still go bankrupt. MPW has learned from this and now scrutinizes new tenants significantly more carefully.
5. My Position — Transparent
229 shares, average price €5.45, current price €4.41. Book loss €237. Dividends received: €119. Net position: −€118 at the time of this recording.
This is my biggest open wound in the portfolio. I am holding the position for three reasons:
- Turnaround is real: Q4 2025 showed profitability for the first time again. California deal secures $45M/year for 15 years.
- Dividend stable: Confirmed at $0.09. At 7.4% yield, waiting for normalization is paid.
- Mid-cycle positioning: REITs tend to recover strongly when rates fall. At a Fed pivot from 2027, MPW could benefit disproportionately.
6. Q1 2026 Earnings Analysis — What Must Happen
Q1 2026 results were published on April 30, 2026 (before market open). My decision framework going into the numbers:
- MUST: Positive NFFO (Normalized FFO) — the core operating metric for REITs. Negative NFFO would be a warning signal.
- MUST: Dividend confirmed at $0.09 for Q2 2026 — no further cut allowed without immediate position reduction.
- SHOULD: California deal running on track — $45M annually progressing as planned.
- BONUS: Commentary on new tenant pipeline — further stabilization following the Steward restructuring.
The series continues with REIT #02 STAG Industrial and the Pharma series (Novo Nordisk, Bayer, Pfizer). MPW stays on my watchlist — the story is not over yet.